Lung cancer continues to be a worldwide problem with more people dying of the disease than prostate, breast and colon cancers combined.1 At present, the majority of new lung cancer cases are recognized at a late stage, which limits treatment options and can significantly reduce the opportunity to improve patient survical.2
This has a life-threatening consequence for patients and a potential crisis for health systems; innovative and cost-efficient solutions must be found to help diagnose patients quicker, so they can receive earlier the treatment that works best for them.
85% of lung cancer cases are caused by smoking.3
74% of lung cancer cases are diagnosed at a late stage.4,5
25% of all cancer deaths globally are linked to tobacco use.3
Lung cancer is the most commonly diagnosed cancer (11.6 % of the total cases) and the leading cause of cancer death (18.4 % of the total cancer deaths).6
12.6% is the 5 year survival rates for lung cancer.7
Together we can further optimize health outcomes through early diagnosis and early recovery, combining innovative technologies and comprehensive medical education programmes for all healthcare providers involved in patient care.
Together we can refine patients' journey through the care continuum enabling them to get deeper understanding and better preparation.
Together we can offer solutions that streamline the patient pathway and optimize the care continuum through enhancing partnerships that combine managed services, consultative expertise and innovative technology.
1. Lung Cancer Survival Rates | 5-Year Survival Rates for Lung Cancer [Internet]. Cancer.org. 2021 [cited 22 October 2021]. Available from: https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/survival-rates.html
2. How quickly does lung cancer spread? Your FAQs [Internet]. Medicalnewstoday.com. 2021 [cited 22 October 2021]. Available from: https://www.medicalnewstoday.com/articles/how-fast-lung-cancer-spreads
3. Tobacco use causes almost one third of cancer deaths in the WHO European Region Feb 2020. https://www.euro.who.int/en/ health-topics/disease-prevention/tobacco/news/news/2020/2/tobacco-use-causes-almost-one-third-of-cancer-deaths-inthe- who-european-region
4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8. PMID: 31912902.
5. Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinicoecon Outcomes Res. 2017 May 12;9:261-269. doi: 10.2147/CEOR.S132259. PMID: 28553128; PMCID: PMC544003
6. Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394-424.
7. Lung cancer - ERS [Internet]. Erswhitebook.org. 2021 [cited 22 October 2021]. Available from: https://www.erswhitebook.org/chapters/lung-cancer/
8. Blandin Knight Sean, Crosbie Phil A., Balata Haval, Chudziak Jakub, Hussell Tracy and Dive Caroline 2017Progress and prospects of early detection in lung cancerOpen Biol.7170070170070 http://doi.org/10.1098/rsob.170070